Wei‐Lien Wang

The University of Texas MD Anderson Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 26 papers. Top paper: “Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial”.

Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(22)00638-6

N/A

2.5DataRank · unranked

77 citations

Roland L. Bassett, Devarati Mitra, Ahsan Farooqi, Caroline Hempel, Courtney Dorber +17 more

B cells are associated with survival and immunotherapy response in sarcoma

Nature(2020)10.1038/s41586-019-1906-8

N/A

1.1DataRank · unranked

1854 citations

Aurélien de Reyniès, Emily Z. Keung, Tom Wei‐Wu Chen, Cheng‐Ming Sun, Julien Caldéraro +24 more

Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT‐STS): Updated local control, late toxicities, and patient‐reported outcomes

Cancer(2024)10.1002/cncr.35542

N/A

0.632DataRank · unranked

16 citations

Devarati Mitra, Ahsan Farooqi, David Swanson, Caroline Hempel, Tiara Willis +17 more

Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000960

N/A

0DataRank · unranked

61 citations

Kathryn Bollin, Mariana Petaccia de Macêdo, Fernando C. L. Carapeto, Kevin B. Kim, Jason Roszik +12 more

Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma

Cell Reports(2021)10.1016/j.celrep.2020.108678

N/A

0DataRank · unranked

49 citations

Katharine E. Caldwell, Charles R. Schutt, Caitlyn B. Brashears, Bethany C. Prudner, William Ehrhardt +11 more

Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas

Cancer(2021)10.1002/cncr.33542

N/A

0DataRank · unranked

35 citations

Meijun Z. Lundberg, Elizabeth G. Demicco, Joanna Przybył, Magdalena Matusiak, Frédéric Chibon +10 more

Combined VEGFR and MAPK pathway inhibition in angiosarcoma

Scientific Reports(2021)10.1038/s41598-021-88703-9

N/A

0DataRank · unranked

34 citations

Yasmin A. Lyons, Jean Siedel, Robert Dood, Archana S. Nagaraja, Monika Haemmerle +8 more

Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy

Cell Reports(2021)10.1016/j.celrep.2021.109410

N/A

0DataRank · unranked

31 citations

Ming Tang, Mayinuer Maitituoheti, Ayush T. Raman, Archit K. Ghosh, Jonathan E. Schulz +21 more

The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma

Nature Communications(2022)10.1038/s41467-022-30710-z

N/A

0DataRank · unranked

31 citations

Mayinuer Maitituoheti, Brian A. Menegaz, Sandhya Krishnan, Amelia M. Vetter, Pamela Camacho +25 more

A phase I/II trial evaluating the safety and efficacy of eribulin in combination with copanlisib in patients with metastatic triple-negative breast cancer (TNBC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps1128

N/A

0DataRank · unranked

4 citations

Leslie Nehring, J. L. Anderson, Brittney Haas, Jingqin Luo, Meghna S. Trivedi +10 more

The Androgen Receptor: A Therapeutic Target in Desmoplastic Small Round Cell Sarcoma

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.20.477146

N/A

0DataRank · unranked

0 citations

Mayinuer Maitituoheti, Brian A. Menegaz, Sandhya Krishnan, Amelia M. Vetter, Pamela Camacho +25 more

Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3629

N/A

0DataRank · unranked

21 citations

Justin T. Moyers, Jason Roszik, Shiraj Sen, David S. Hong, Aung Naing +29 more

Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1703

N/A

0DataRank · unranked

10 citations

Richard K. Yang, Alexander J. Lazar, Shalin S. Patel, Valerae O. Lewis, Jason Roszik +13 more

Complete loss of TP53 and RB1 is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma

Human Genetics and Genomics Advances(2023)10.1016/j.xhgg.2023.100224

N/A

0DataRank · unranked

7 citations

Chia-Chin Wu, Michael S. Nakazawa, Davis R. Ingram, Joseph R. Daniele, Rossana Lazcano +14 more

PEPN1924, a phase 2 study of trastuzumab deruxtecan (DS-8201a, T-DXd) in adolescents and young adults with recurrent HER2+ osteosarcoma: A children’s oncology group pediatric early-phase clinical Trial Network study.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11527

N/A

0DataRank · unranked

11 citations

Katherine A. Janeway, Charles G. Minard, David Hall, Brian D. Crompton, Alexander J. Lazar +8 more

A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma

Nature Cancer(2024)10.1038/s43018-024-00726-z

N/A

0DataRank · unranked

58 citations

Elise F. Nassif, Emily Z. Keung, Wei‐Lien Wang, Alexander J. Lazar, Heather Lin +54 more

Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-006991

N/A

0DataRank · unranked

36 citations

Alexander J. Lazar, Davis R. Ingram, Wei‐Lien Wang, Wendong Zhang, Zhiliang Jia +7 more

Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.10.021

N/A

0DataRank · unranked

32 citations

Jieling Miao, Karen L. Reckamp, Carl M. Gay, Lauren A. Byers, Ying‐Qi Zhao +15 more

Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-1763

N/A

0DataRank · unranked

13 citations

Virginia Giuliani, Wei‐Lien Wang, Daniel J. McGrail, Christopher A. Bristow, Natalie Y.L. Ngoi +46 more

Bone mimetic environments support engineering, propagation, and analysis of therapeutic response of patient-derived cells, ex vivo and in vivo

Acta Biomaterialia(2024)10.1016/j.actbio.2024.02.025

N/A

0DataRank · unranked

7 citations

Vanessa Parietti, Sergio Barrios, Peter D.A. Shepherd, Tianhong Pan, Wei‐Lien Wang +7 more

Targeting IL-11R/EZH2 signaling axis as a therapeutic strategy for osteosarcoma lung metastases

Discover Oncology(2024)10.1007/s12672-024-01056-3

N/A

0DataRank · unranked

1 citations

R. Eric Davis, Hannah C. Beird, Wei‐Lien Wang, V. Behrana Jensen, Arumugam Jayakumar +8 more

Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0761

N/A

0DataRank · unranked

3 citations

Ian M. Silverman, Victoria Rimkunas, Artur Veloso, Dominik Głodzik, Adrienne Johnson +16 more

Impact of ATRX loss on survival and immune microenvironment in multiple sarcoma subtypes.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.11511

N/A

0DataRank · unranked

3 citations

Rossana Lazcano Segura, Ahsan Farooqi, Davis R. Ingram, Khalida Wani, Yiming Cai +13 more

CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3324

N/A

0DataRank · unranked

7 citations

Menuka Karki, Kyle A. Blum, Jean‐Philippe Bertocchio, Rong He, Durga Nand Tripathi +17 more

Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-1824

N/A

0DataRank · unranked

215 citations

Melissa Burgess, Ruth Salazar, Edwin R. Parra, Jaime Rodrigues-Canales, Vanessa Bolejack +18 more

Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma

Cell Reports(2020)10.1016/j.celrep.2020.108293

N/A

0DataRank · unranked

70 citations

Emily Z. Keung, Ming Tang, Yan Liang, Hunain Alam, Guangchun Han +27 more